A key part of this transformation has been the cornerstone investment by Realtek, now Nuheara’s largest shareholder. Underpinning this investment is Nuheara’s technology and product development leadership position in the global hearing industry.
The OTC hearing market, currently in the US, is rapidly evolving into a global market, with several companies considering how best they can navigate the complex product development and FDA and other regulatory pathways to market. As a result, new and exciting potential revenue streams with Original Equipment Manufacturers (OEMs) and Original Design Manufacturers (ODMs) are emerging from the Realtek partnership and Nuheara’s unique ability to deliver turnkey hearing technology solutions.
In response,
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/307dcd0c-0b92-4c7f-9d53-8f2bc541b2c6
The following appointments have been made to Nuheara’s senior executive team:
Christophe Chene as SVP Strategic Growth based inTaiwan . Christophe had been contracting to the Company since CES inJanuary 2023 and has 30-years’ experience in driving large OEM/ODM deals in the semi-conductor industry and brings a wealth of knowledge and contacts to spearhead Nuheara’s business to business initiatives.Ivan Kelly as Chief Financial Officer (CFO). Ivan is a seasoned corporate finance executive with extensive finance and investor relations working experience acrossEurope ,Australia and most recently in the US.
The Company also plans to strengthen its medical device compliance and regulatory capabilities, currently undertaking a search process for a Head of Compliance, Regulatory and Legal.
The following executive reassignments have been undertaken:
- Dr
Alan Davis , formerly Chief Product officer (CPO) has been appointed Chief Technology Officer (CTO), a role more fitting of the technology expertise he and his team provides across both retail and strategic opportunities. - Nick O’Loughlin, formerly Chief Innovation Officer (CIO) has been appointed Chief Operations Officer (COO). Nick’s prior knowledge of new products and offshore manufacturing with SharkNinja provides the business with the necessary experience for scale up.
Nuheara Chairperson Hon.
“The Company has undertaken a successful transformation in recent years, as it has pursued medical device excellence and the emerging market of OTC Hearing Aids. New strategic investment, Board appointment and a restructured executive team will underpin Nuheara’s future as a medical device company. We have worked hard for this opportunity, and I have confidence in the refreshed Board and Executive team’s ability to execute on the very exciting growth opportunities we see for our business.”
AUTHORISED BY: | INVESTORS: |
Hon. Chairperson | Email: ronn.bechler@automicgroup.com.au Phone: + 61 400 009 774 |
MEDIA – US: | MEDIA – |
Ranya Alkadamani | |
Email: nuheara@firebrand.marketing | Email: ranya@impactgroupinternational.com |
Phone: +1 415 848 9175 | Phone: +61 434 664 589 |
ABOUT
In 2016, the Company released its revolutionary wireless earbuds, IQbuds, which allow consumers to augment their hearing according to their personal hearing preferences and connect hands free with their voice-enabled smart devices. In 2020
In 2021,
The Company’s mission is to transform the way people hear by creating smart hearing solutions that are both accessible and affordable. For further information, please visit https://www.nuheara.com/.
Organizational Chart
Executive Roles and Responsibilities
2023 GlobeNewswire, Inc., source